BMC Infect Dis. 2022 Dec 3;22(1):902. doi: 10.1186/s12879-022-07889-z.
NO ABSTRACT
PMID:36461006 | DOI:10.1186/s12879-022-07889-z
Categories
Sotrovimab use in Japanese inpatients with COVID-19: post-infusion adverse events
